Detail
| LncRNA Name | CASC9 |
| Synonyms | CASC9, ESCCAL-1, ESSCAL1, LINC00981, ESCCAL-1 |
| Region | GRCh38_8:75223404-75324741 Sequence |
| Ensembl | ENSG00000249395 |
| RefSeq | NR_103848 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | esophageal squamous cell cancer |
| ICD-0-3 | |
| Methods | qPCR, Western blot |
| Sample | esophageal squamous cell carcinoma tissues, cell lines (KYSE30,KYSE150, TE-1, Eca-109,HEEpiC) |
| Expression Pattern | up-regulated |
| Function Description | CASC9 expression is independent Multivariate analysis showed prognostic indicators of overall survival and disease-free survival.inhibition of CASC9 can inhibit the proliferation, migration and invasion of ESCC. Abnormal CASC9 expression can regulate the expression level of markers EMT. |
| Pubmed ID | 29424900 |
| Year | 2018 |
| Title | LncRNA CASC9 promotes tumorigenesis by affecting EMT and predicts poor prognosis in esophageal squamous cell cancer. |
| External Links |
| Links for CASC9 | GenBank HGNC lncrnadb Noncode |
| Links for esophageal squamous cell cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.